Abstract:Patients who survive the initial ictus of spontaneous intracerebral hemorrhage (ICH) remain vulnerable to subsequent injury of the perilesional parenchyma by molecular and cellular responses to the hematoma. Secondary brain injury after ICH, which contributes to long-term functional impairment and mortality, has emerged as an attractive therapeutic target. This review summarizes preclinical and clinical evidence for neuroprotective therapies targeting secondary injury pathways following ICH. A focus on therapies with pleiotropic antiinflammatory effects that target thrombin-mediated chemotaxis and inflammatory cell migration has led to studies investigating statins, anticholinergics, sphingosine-1-phosphate receptor modulators, peroxisome proliferator activated receptor gamma agonists, and magnesium. Attempts to modulate ICH-induced blood–brain barrier breakdown and perihematomal edema formation has prompted studies of nonsteroidal antiinflammatory agents, matrix metalloproteinase inhibitors, and complement inhibitors. Iron chelators, such as deferoxamine and albumin, have been used to reduce the free radical injury that ensues from erythrocyte lysis. Stem cell transplantation has been assessed for its potential to enhance subacute neurogenesis and functional recovery. Despite promising preclinical results of numerous agents, their outcomes have not yet translated into positive clinical trials in patients with ICH. Further studies are necessary to improve our understanding of the molecular events that promote damage and inflammation of the perihematomal parenchyma after ICH. Elucidating the temporal and pathophysiologic features of this secondary brain injury could enhance the clinical efficacy of neuroprotective therapies for ICH.

Ion Channel Dysregulation Following Intracerebral Hemorrhage

Ion Channel Blockers And Spinal Cord Injury

Magnesium: Pathophysiological mechanisms and potential therapeutic roles in intracerebral hemorrhage

Gap Junctions and Hemichannels Composed of Connexins and Pannexins Mediate the Secondary Brain Injury Following Intracerebral Hemorrhage

Mechanism and Therapy of Brain Edema after Intracerebral Hemorrhage.

Secondary mechanisms of injury and viable pathophysiological targets in intracerebral hemorrhage

MicroRNAs Modulate Neuroinflammation after Intracerebral Hemorrhage: Prospects for New Therapy.

Immune-mediated disruption of the blood-brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets

Brain edema formation and therapy after intracerebral hemorrhage

Drug development in targeting ion channels for brain edema

Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage

Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage.

Ionic Regulation of Cell Volume Changes and Cell Death after Ischemic Stroke

Modes of Brain Cell Death Following Intracerebral Hemorrhage

Neuroprotective Therapies for Spontaneous Intracerebral Hemorrhage

Mechanisms and potential therapeutic targets for spontaneous intracerebral hemorrhage

White Matter Injury After Intracerebral Hemorrhage

Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage

Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage

White Matter Injury after Intracerebral Hemorrhage: Pathophysiology and Therapeutic Strategies.

Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): From mechanisms to translation